Uniqure N.V. (QURE)

$21.33 -1.41 (-6.20%)
Market Cap 1.33B
Revenue (ttm) 27.12M
Net Income (ttm) -239.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -883.33%
Debt to Equity Ratio 0.23
Volume 3,495,400
Avg Vol 3,831,406
Day's Range N/A - N/A
Shares Out 62.29M
Stochastic %K 8%
Beta 0.59
Analysts Strong Sell
Price Target $58.50

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
wrengler4
wrengler4 Dec. 6 at 11:58 AM
$QURE try dead money , for more than a month it took to sky rocket , lol..for Kapusta to sell ! Never a good stock for a portfolio. Not with an ex stock broker at the helm
0 · Reply
wrengler4
wrengler4 Dec. 6 at 11:57 AM
$QURE for a while …try 5 years if they keep Kapusta
0 · Reply
wrengler4
wrengler4 Dec. 6 at 11:56 AM
$QURE deserved..Kapusta is not, never was a scientist, nor a polished CEO...he is a scum stock broker ( probably a relative of a board member , who has dementia )
0 · Reply
TheRoaringBunny
TheRoaringBunny Dec. 5 at 11:13 PM
$AXGN $CEP $FRSX $QURE You have less than 2 hours to grab $PLBY The next global meme stock runs on Monday
1 · Reply
Thinkingman91
Thinkingman91 Dec. 5 at 10:34 PM
$QURE this bottom it will fluctuate this line
0 · Reply
Mrfudd
Mrfudd Dec. 5 at 9:03 PM
$QURE well theres your close. Moving goal post from 23 is the bottom to its just intra day to im not scared lol
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Dec. 5 at 7:40 PM
$QURE they are just slaughtering this thing again-no mercy.
0 · Reply
Mrfudd
Mrfudd Dec. 5 at 5:39 PM
$QURE the goalpost mover is going to have to move them again
1 · Reply
Mrfudd
Mrfudd Dec. 5 at 5:36 PM
$QURE not looking good for you bro
0 · Reply
jewell69
jewell69 Dec. 5 at 5:35 PM
12/4 bot $CAFRX africa mutual fund; fidelity is reporting 3 year 17.83% and 14.76% no kidding 1 year 34.64 ytd 42.46% I paid 11.34 it totally smokes $TRAMX $TROW AFRICA and Middle East. $QURE DOWN ANOTHE -7.65% TODAY 12/5 ON THE HEELS OF A VERY BAD DAY 12/4 ALSO. FDA PRETTY MUCH DID A "NO-CAN-DO" (that's a scientific term) on their huntington's diseas. price at 21.01 right now. I sold out of it in the 14's for small medium profit and forgot about it.
0 · Reply
Latest News on QURE
Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 1:30 PM EST - 2 days ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 2 days ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Diamond Hill International Strategy Q3 2025 Performance Review

Nov 17, 2025, 8:59 AM EST - 19 days ago

Diamond Hill International Strategy Q3 2025 Performance Review

BABA HDB TSM

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 22 days ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Nov 12, 2025, 10:00 AM EST - 24 days ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

Nov 10, 2025, 12:44 PM EST - 26 days ago

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 11:11 AM EST - 26 days ago

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 26 days ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 4 weeks ago

uniQure to Announce Third Quarter 2025 Financial Results

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

Nov 3, 2025, 1:04 PM EST - 4 weeks ago

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Nov 3, 2025, 10:01 AM EST - 4 weeks ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Nov 3, 2025, 9:58 AM EST - 4 weeks ago

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

ABBV ALNY AMGN BMY LLY MBX MDGL

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

Nov 3, 2025, 8:11 AM EST - 4 weeks ago

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

Nov 3, 2025, 7:18 AM EST - 4 weeks ago

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

Oct 28, 2025, 1:55 PM EDT - 5 weeks ago

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

Oct 8, 2025, 3:33 PM EDT - 2 months ago

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Sep 29, 2025, 4:05 PM EDT - 2 months ago

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

uniQure Announces Pricing of Upsized $300 Million Public Offering

Sep 25, 2025, 11:38 PM EDT - 2 months ago

uniQure Announces Pricing of Upsized $300 Million Public Offering

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

Sep 25, 2025, 8:37 AM EDT - 2 months ago

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

uniQure Stock Jumps On Positive News, But Risks Remain

Sep 25, 2025, 7:23 AM EDT - 2 months ago

uniQure Stock Jumps On Positive News, But Risks Remain

UniQure: How QURE Stock Rises 10x To $500?

Sep 25, 2025, 6:20 AM EDT - 2 months ago

UniQure: How QURE Stock Rises 10x To $500?

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

Sep 24, 2025, 4:37 PM EDT - 2 months ago

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

Sep 24, 2025, 4:24 PM EDT - 2 months ago

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

uniQure Announces $200 Million Proposed Public Offering

Sep 24, 2025, 4:06 PM EDT - 2 months ago

uniQure Announces $200 Million Proposed Public Offering

uniQure N.V. - Special Call

Sep 24, 2025, 1:03 PM EDT - 2 months ago

uniQure N.V. - Special Call

QURE stock skyrockets 200% on ‘three' big news

Sep 24, 2025, 11:20 AM EDT - 2 months ago

QURE stock skyrockets 200% on ‘three' big news

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

Sep 24, 2025, 10:23 AM EDT - 2 months ago

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

UniQure's brain disorder drug slows disease progression in trial

Sep 24, 2025, 7:28 AM EDT - 2 months ago

UniQure's brain disorder drug slows disease progression in trial

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

Sep 24, 2025, 7:10 AM EDT - 2 months ago

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

Sep 24, 2025, 7:05 AM EDT - 2 months ago

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

Sep 5, 2025, 4:57 PM EDT - 3 months ago

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Sep 5, 2025, 7:05 AM EDT - 3 months ago

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 4 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA RCKT

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 9:07 PM EDT - 4 months ago

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

uniQure Narrows Loss in Fiscal Q2

Jul 29, 2025, 9:34 AM EDT - 4 months ago

uniQure Narrows Loss in Fiscal Q2

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Jul 29, 2025, 7:05 AM EDT - 4 months ago

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:05 AM EDT - 4 months ago

uniQure to Announce Second Quarter 2025 Financial Results

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

Jun 11, 2025, 8:00 AM EDT - 6 months ago

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

May 28, 2025, 4:56 AM EDT - 6 months ago

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

May 19, 2025, 8:00 AM EDT - 7 months ago

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

AKTX CRBP

uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:16 PM EDT - 7 months ago

uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript

uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress

May 9, 2025, 7:05 AM EDT - 7 months ago

uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data

May 8, 2025, 5:16 AM EDT - 7 months ago

uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data

uniQure to Announce First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 7 months ago

uniQure to Announce First Quarter 2025 Financial Results

uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130

Apr 21, 2025, 1:56 AM EDT - 8 months ago

uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130

wrengler4
wrengler4 Dec. 6 at 11:58 AM
$QURE try dead money , for more than a month it took to sky rocket , lol..for Kapusta to sell ! Never a good stock for a portfolio. Not with an ex stock broker at the helm
0 · Reply
wrengler4
wrengler4 Dec. 6 at 11:57 AM
$QURE for a while …try 5 years if they keep Kapusta
0 · Reply
wrengler4
wrengler4 Dec. 6 at 11:56 AM
$QURE deserved..Kapusta is not, never was a scientist, nor a polished CEO...he is a scum stock broker ( probably a relative of a board member , who has dementia )
0 · Reply
TheRoaringBunny
TheRoaringBunny Dec. 5 at 11:13 PM
$AXGN $CEP $FRSX $QURE You have less than 2 hours to grab $PLBY The next global meme stock runs on Monday
1 · Reply
Thinkingman91
Thinkingman91 Dec. 5 at 10:34 PM
$QURE this bottom it will fluctuate this line
0 · Reply
Mrfudd
Mrfudd Dec. 5 at 9:03 PM
$QURE well theres your close. Moving goal post from 23 is the bottom to its just intra day to im not scared lol
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Dec. 5 at 7:40 PM
$QURE they are just slaughtering this thing again-no mercy.
0 · Reply
Mrfudd
Mrfudd Dec. 5 at 5:39 PM
$QURE the goalpost mover is going to have to move them again
1 · Reply
Mrfudd
Mrfudd Dec. 5 at 5:36 PM
$QURE not looking good for you bro
0 · Reply
jewell69
jewell69 Dec. 5 at 5:35 PM
12/4 bot $CAFRX africa mutual fund; fidelity is reporting 3 year 17.83% and 14.76% no kidding 1 year 34.64 ytd 42.46% I paid 11.34 it totally smokes $TRAMX $TROW AFRICA and Middle East. $QURE DOWN ANOTHE -7.65% TODAY 12/5 ON THE HEELS OF A VERY BAD DAY 12/4 ALSO. FDA PRETTY MUCH DID A "NO-CAN-DO" (that's a scientific term) on their huntington's diseas. price at 21.01 right now. I sold out of it in the 14's for small medium profit and forgot about it.
0 · Reply
Ontherag
Ontherag Dec. 5 at 5:28 PM
$QURE dead money for awhile, this will continue to go down because the market doesn’t have time to wait, everyone wants quick money these days
0 · Reply
Mrfudd
Mrfudd Dec. 5 at 3:45 PM
$QURE fine
1 · Reply
Ottoman_trader
Ottoman_trader Dec. 5 at 2:34 PM
$QURE lets do this fly
0 · Reply
Janestockaddiction
Janestockaddiction Dec. 5 at 12:54 PM
$QURE Rock it
0 · Reply
wrengler4
wrengler4 Dec. 5 at 11:50 AM
$QURE no ..back to $13 from where it came before Leerink did the offering in March 2025 for CASH , hahahaha Then the BIG LIE came, no not the election lie, Matt’s Lie of 2025, he knowledge that push back existed on how they ran the trial and he had to pull off more cash to survive the next 12 months . He is the kryptonite of QURE
1 · Reply
wrengler4
wrengler4 Dec. 5 at 11:47 AM
$QURE how ??? Like a fart in church …doesn’t go over well
0 · Reply
wrengler4
wrengler4 Dec. 5 at 11:46 AM
$QURE No CEO sells 9M , unless : They had a true sense that the FDA was giving them push back and he said “ I’m getting the fcuk out, I’ll have to acknowledge this set back.” And that’s the true story, and I’ll stick to it !!! Now he doesn’t give a dam, until he accumulates more shares quarterly and can sell again ….a true slime bal
0 · Reply
Willdowdell
Willdowdell Dec. 4 at 10:53 PM
$QURE how does potential new FDA position on fewer trials impact these guys?
0 · Reply
Thinkingman91
Thinkingman91 Dec. 4 at 9:38 PM
$QURE how you feel about it 🤷🏼‍♂️
0 · Reply
MAGA1717
MAGA1717 Dec. 4 at 8:47 PM
$QURE how many times does one have to be told what max pain bottom is? Id listen to thinkingman if i were you. hes like novicaine. give him time and he works everytime
0 · Reply
Ottoman_trader
Ottoman_trader Dec. 4 at 8:37 PM
$QURE Bye bye shorts , daddy will fly.
0 · Reply
only1de
only1de Dec. 4 at 7:55 PM
$QURE until this is resolved with the FDA and the meeting could be in March, it will continue to drift. Since my avg. was $12, I took some profits, held some and will wait for it to hit the teens again and buy more. This worked perfectly for $VKTX years ago when Mash was the only thing discussed and more recently with $JOBY when it hit $20. Now the HD patients and their docs need to let the FDA know how they feel. It’s like Animal House at the FDA.
0 · Reply